Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost after uncomplicated cataract surgery
ACTRN12606000265572Phase 4Not yet recruiting
- Sponsor
- Federal University of Uberlândia
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cystoid macular edema (CME) comparing Latanoprost with Placebo (2 arms). Primary endpoint: Macular thickness changes. Planned start Aug 2006; status: not yet recruiting.
02
Drugs
latanoprost
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on ACTRN12606000265572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000265572.